Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Investing Ideas
Browse All Stocks
Markets
Investing Ideas
›
Potentially Undervalued Companies
Edit Screener
Get New Stock Alert
Potentially Undervalued Companies
Results
42
Companies with a Value score of at least 3, ordered by Value score
🇨🇭 CH Market
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Pharmaceuticals & Biotech
All Industries
Automobiles
Banks
Capital Goods
Commercial Services
Consumer Durables
Consumer Services
Diversified Financials
Energy
Consumer Retailing
Food, Beverage & Tobacco
Healthcare
Household
Insurance
Materials
Media
Pharmaceuticals & Biotech
Real Estate
Retail
Semiconductors
Software
Tech
Telecom
Transportation
Utilities
42 companies
0 new companies last 7d
Company
Last Price
7D Return
1Y Return
Market Cap
Analysts Target
Valuation
Growth
Div Yield
KURN
Kuros Biosciences
CHF 23.40
-0.6%
-14.7%
CHF 928.3m
CHF 33.86
PE
467.1
E
61.1%
n/a
GXI
Gerresheimer
CHF 25.28
-1.7%
-66.6%
CHF 913.9m
CHF 25.94
PS
0.4
E
99.4%
0%
VTRS
Viatris
CHF 14.24
-2.3%
n/a
CHF 20.6b
CHF 14.47
PS
1.4
E
54.5%
2.7%
EVT
Evotec
CHF 4.63
0%
n/a
CHF 609.7m
CHF 6.61
PS
0.8
E
72.5%
n/a
BMY
Bristol-Myers Squibb
CHF 51.50
-1.0%
n/a
CHF 134.6b
CHF 53.59
PE
14.0
E
-6.9%
4.0%
BSLN
Basilea Pharmaceutica
CHF 50.70
-3.2%
-5.4%
CHF 628.5m
CHF 86.88
PE
15.6
E
7.8%
n/a
JCARE
Joincare Pharmaceutical Group IndustryLtd
US$8.00
0%
0%
US$18.0b
US$12.24
PE
13.7
E
8.6%
2.2%
NVAX
Novavax
CHF 6.14
2.0%
n/a
CHF 1.3b
CHF 11.26
PS
2.1
E
63.4%
n/a
SANN
Santhera Pharmaceuticals Holding
CHF 14.94
4.5%
8.7%
CHF 223.7m
CHF 27.50
PS
2.9
S
18.6%
n/a
000982352
AstraZeneca
CHF 124.91
-12.3%
3.1%
CHF 186.7b
CHF 162.95
PE
24.1
E
13.1%
2.0%
1CG
CRISPR Therapeutics
CHF 39.10
2.9%
-13.6%
CHF 5.2b
CHF 64.26
PS
390.3
E
69.7%
n/a
ROP
Roche Holding
CHF 364.70
0.8%
46.7%
CHF 285.6b
CHF 363.92
PE
23.5
E
10.3%
2.7%
TECN
Tecan Group
CHF 193.80
4.5%
25.4%
CHF 2.4b
CHF 175.48
PS
2.8
E
48.0%
1.5%
J7Z
Jazz Pharmaceuticals
CHF 209.03
-0.5%
n/a
CHF 17.0b
CHF 223.92
PE
18.0
E
17.4%
n/a
NOVN
Novartis
CHF 124.46
-4.1%
34.7%
CHF 236.6b
CHF 124.36
PE
23.0
E
11.0%
2.9%
QIA
Qiagen
CHF 50.36
0%
0%
CHF 9.2b
CHF 61.37
PE
27.0
E
11.3%
n/a
ILMN
Illumina
CHF 129.57
0%
n/a
CHF 20.6b
CHF 131.10
PE
24.2
E
8.3%
n/a
SAN
Sanofi
CHF 73.20
0%
n/a
CHF 89.1b
CHF 92.94
PE
22.6
E
19.6%
5.5%
MMTX
MindMaze Therapeutics Holding
CHF 0.24
21.8%
n/a
CHF 36.0m
CHF 2.73
PS
56.1
E
87.7%
n/a
GILD
Gilead Sciences
CHF 105.02
-3.8%
n/a
CHF 167.8b
CHF 125.43
PS
5.4
E
45.4%
2.5%
BANB
Bachem Holding
CHF 73.00
-0.8%
10.7%
CHF 5.5b
CHF 82.80
PE
36.7
E
18.2%
1.2%
OFK
Orion Oyj
CHF 75.93
-0.9%
n/a
CHF 11.5b
CHF 71.12
PE
19.6
E
8.6%
2.2%
RO
Roche Holding
CHF 370.00
-0.4%
42.2%
CHF 291.1b
CHF 369.21
PE
23.5
E
10.3%
2.7%
NNFN
MannKind
CHF 3.30
3.0%
n/a
CHF 1.3b
CHF 6.51
PS
3.6
E
53.4%
n/a
Page 1 of 2
Dashboard
Portfolios
Watchlist
Community
Discover
Screener
EN